Leading pharmacy benefit managers are shifting away from lucrative rebates on biologic drugs and toward lower-cost biosimilar ...

The CEOs of CVS Health and UnitedHealth Group praised pharmacy benefit managers and promised transparency during investor ...

CVS Health Corporation’s CVS share price has dipped by 6.47%, which has investors questioning if this is right time to buy.

CVS Health subsidiary CVS Caremark, Cigna division Express Scripts and UnitedHealth Group unit OptumRx collectively hold 70% of the PBM market, according to the American Medical Association.

CVS Health (CVS) is a top S&P 500 performer in 2025, with year-to-date returns exceeding 50%. Moreover, the stock has shirked ...

CVS Health CEO David Joyner earned $17.8 million in total compensation in 2024. The company reported compensation data for its six highest-paid executives in its annual proxy report, published April 4 ...

Arkansas Gov. Sarah Sanders has signed a first-in-the-nation law that prohibits PBMs from operating both retail and ...

Tuesday, lawmakers in Arkansas advanced a bill that would essentially eliminate a popular pharmacy chain in the Natural State ...

A House committee stripped the provision that made PBM executives sweat, but Senate Bill 140 still has some meat.

CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report to Prem ...

Brian Newman will guide CVS’ finances at a challenging time for the retail pharmacy and health insurance giant. Still, CVS ...

Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $74.12, accompanied by ...